Drug Therapy Protocols: Glucose gel

Drug Therapy Protocols: Glucose gel
Disclaimer and copyright
©2016 Queensland Government
All rights reserved. Without limiting the reservation of copyright, no person shall reproduce, store in a
retrieval system or transmit in any form, or by any means, part or the whole of the Queensland Ambulance
Service (‘QAS’) Clinical practice manual (‘CPM’) without the priorwritten permission of the Commissioner.
The QAS accepts no responsibility for any modification, redistribution or use of the CPM or any part
thereof. The CPM is expressly intended for use by QAS paramedics whenperforming duties and delivering
ambulance services for, and on behalf of, the QAS.
Under no circumstances will the QAS, its employees or agents, be liable for any loss, injury, claim, liability
or damages of any kind resulting from the unauthorised use of, or reliance upon the CPM or its contents.
While effort has been made to contact all copyright owners this has not always been possible. The QAS
would welcome notification from any copyright holder who has been omitted or incorrectly acknowledged.
All feedback and suggestions are welcome, please forward to:
[email protected]
Date
October, 2015
Purpose
Scope
Author
To ensure a consistent procedural approach to Glucose gel administration.
Applies to all QAS clinical staff.
Clinical Quality & Patient Safety Unit, QAS
Review date
October, 2017
URL
https://ambulance.qld.gov.au/clinical.html
This work is licensed under the Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0
International License. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Glucose gel
October, 2015
Drug class
Side effects
Hyperglycaemic
UNCONTROLLED WHEN PRINTED
Pharmacology
• Nausea and/or vomiting
Glucose gel is a form of pure glucose that is absorbed quickly in the
intestinal tract after ingestion. It is the principal energy source for body cells especially the brain. [1,2]
• Diarrhoea
Presentation
Metabolism
Glucose is broken down in most tissues and distributed throughout
total body water.[1] UNCONTROLLED WHEN PRINTED
• Tube, 15 g glucose (Glutose 15™)
Indications
• Symptomatic hypoglycaemia (with the ability to self-administer oral glucose)
Onset
Duration
Half-life
≈ 10 minutes
Variable
Not applicable
UNCONTROLLED WHEN PRINTED
Contraindications
• Unconsciousness
• Patients with difficulty swallowing
• Patients < 2 years
Schedule
• Unscheduled.
Routes of administration
CCP
ACP2
P
ACP1
FR
UNCONTROLLED WHEN PRINTED
Per oral (PO)
Precautions
• Nil
Figure 4.14
QUEENSLAND AMBULANCE SERVICE
757
Glucose gel
Adult dosages
Symptomatic hypoglycaemia (with the ability to UNCONTROLLED
WHEN
PRINTED
P
CCP
ACP2
FR
ACP1
self-administer oral glucose)
PO
15 g
Repeated once at 15 minutes
if BGL ≤ 4.0 mmol/L. Total maximum dose 30 g.
UNCONTROLLED WHEN PRINTED
Paediatric dosages
Symptomatic hypoglycaemia (with the ability to CCP
ACP2
P
ACP1
self-administer oral glucose)
PO
≥ 2 years – 15 g
Repeated once at 15 minutes
if BGL ≤ 4.0 mmol/L. Total maximum dose 30 g.
FR
UNCONTROLLED WHEN PRINTED
Special notes
UNCONTROLLED WHEN PRINTED
• Patients are to swallow the entire contents of the tube where
possible, to maximise the rise in blood glucose levels.
726
QUEENSLAND AMBULANCE SERVICE
758